Cargando…

Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer

SIMPLE SUMMARY: Among all types of cancer, Pancreatic Ductal Adenocarcinoma (PDAC) has one of the lowest survival rates, partly due to the failure of current chemotherapeutics. This treatment failure can be attributed to the complicated nature of the tumor microenvironment, where the rich fibro-infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haque, Muhammad R., Rempert, Trevor H., Al-Hilal, Taslim A., Wang, Chengyao, Bhushan, Abhinav, Bishehsari, Faraz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430573/ https://www.ncbi.nlm.nih.gov/pubmed/34503294 http://dx.doi.org/10.3390/cancers13174487

Ejemplares similares

Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
por: Haque, Muhammad R., et al.
Publicado: (2022)

Personalised organs-on-chips: functional testing for precision medicine
por: van den Berg, Albert, et al.
Publicado: (2019)

Precision medicine for acute pancreatitis: current status and future opportunities
por: Mukherjee, Rajarshi, et al.
Publicado: (2019)

Development of Organs-on-Chips and Their Impact on Precision Medicine and Advanced System Simulation
por: Luo, Ying, et al.
Publicado: (2023)

Cancer-on-a-Chip: Models for Studying Metastasis
por: Zhang, Xiaojun, et al.
Publicado: (2022)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma
por: Armstrong, Andrew, et al.
Publicado: (2021)

Organ-on-chip models: new opportunities for biomedical research
por: Mosig, Alexander S.
Publicado: (2016)

Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases
por: Barlass, Usman, et al.
Publicado: (2021)

Response to Rathi et al.
por: Bishehsari, Faraz
Publicado: (2020)

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness
por: Seymour, Christopher W., et al.
Publicado: (2017)

Organ-on-a-Chip: Opportunities for Assessing the Toxicity of Particulate Matter
por: Yang, Jia-Wei, et al.
Publicado: (2020)

The opportunity in African genome resource for precision medicine
por: Fatumo, Segun
Publicado: (2020)

Opportunities for Artificial Intelligence in Advancing Precision Medicine
por: Filipp, Fabian V.
Publicado: (2019)

Epilepsy in the mTORopathies: opportunities for precision medicine
por: Moloney, Patrick B, et al.
Publicado: (2021)

Challenges and opportunities for precision medicine in neurodevelopmental disorders
por: Chen, George T., et al.
Publicado: (2022)

Precision Population Medicine in Primary Care: The Sanford Chip Experience
por: Christensen, Kurt D., et al.
Publicado: (2021)

Precision medicine in human heart modeling: Perspectives, challenges, and opportunities
por: Peirlinck, M., et al.
Publicado: (2021)

SAT-653 Exploring the Role of Brown Adipokines on Hepatic Insulin Resistance Using a Microfluidic Organ-On-Chip
por: Tanataweethum, Nida, et al.
Publicado: (2020)

Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities
por: Wang, Edwin, et al.
Publicado: (2017)

Opportunities for Practices in Precision Population Health and Personalized Medicine
por: Au, William W.
Publicado: (2019)

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
por: Kanzaki, Ryu, et al.
Publicado: (2020)

Precision medicine in severe pediatric asthma: opportunities and challenges
por: Vijverberg, Susanne J.H., et al.
Publicado: (2020)

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine
por: Carloni, Riccardo, et al.
Publicado: (2022)

Precision Medicine in Pancreatitis: The Future of Acute Pancreatitis Care
por: Garami, Andras, et al.
Publicado: (2023)

Inconsistent eating time is associated with obesity: A prospective study
por: Adnan, Darbaz, et al.
Publicado: (2022)

Precision medicine approaches for diabetic kidney disease: opportunities and challenges
por: Tye, Sok Cin, et al.
Publicado: (2021)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities
por: Wästerlid, Tove, et al.
Publicado: (2022)

Human organs-on-chips for disease modelling, drug development and personalized medicine
por: Ingber, Donald E.
Publicado: (2022)

Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)

Tissue Chips in Space—Challenges and Opportunities
por: Yeung, Catherine K., et al.
Publicado: (2019)

Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
por: Al-Hilal, Taslim A., et al.
Publicado: (2020)

Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities
por: Beckmann, Jacques S., et al.
Publicado: (2016)

Colorectal Cancer and Alcohol Consumption—Populations to Molecules
por: Rossi, Marco, et al.
Publicado: (2018)

On-chip modeling of tumor evolution: Advances, challenges and opportunities
por: Li, Chengpan, et al.
Publicado: (2023)

Precision ultrasound sensing on a chip
por: Basiri-Esfahani, Sahar, et al.
Publicado: (2019)

Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities
por: Wang, Yifan, et al.
Publicado: (2020)

Implementation of Electronic Consent at a Biobank: An Opportunity for Precision Medicine Research
por: Boutin, Natalie T., et al.
Publicado: (2016)

Evolutionary Approaches to Combat Antibiotic Resistance: Opportunities and Challenges for Precision Medicine
por: Merker, Matthias, et al.
Publicado: (2020)

Extracellular Vesicles: A Novel Opportunity for Precision Medicine in Respiratory Diseases
por: Carnino, Jonathan M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bl3vt0qln7r93ocksq63l31q0s